SUNNYVALE, Calif., March 25, 2025 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTC-BB:CANSF), a biotechnology company focused on industrial manufacturing of ingredients is pleased to announce its financial and operating results for the three months and year ended December 31, 2024, and an update in respect of the disposition of Company's operating subsidiary (as announced via press release on March 14, 2025). Selected financial and operational information is outlined below and should be read with Willow's audited consolidated financial statements, management's discussion and analysis and annual information form for the year ended December 31, 2024, which are available on SEDAR+ at www.sedarplus.ca.
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/Cybersecurity%20by%20AIBooth%20via%20Shutterstock.jpg)